![Brimica Genuair inhaler (aclidinium bromide / formoterol fumarate dihydrate) Drug / Medicine Information Brimica Genuair inhaler (aclidinium bromide / formoterol fumarate dihydrate) Drug / Medicine Information](https://d2jx2rerrg6sh3.cloudfront.net/images/drugs/fkcbrimg10923/422087.png)
Brimica Genuair inhaler (aclidinium bromide / formoterol fumarate dihydrate) Drug / Medicine Information
![Duaklir 340micrograms/dose / 12micrograms/dose Genuair (Zentiva Pharma UK Ltd) 60 dose - RightBreathe Duaklir 340micrograms/dose / 12micrograms/dose Genuair (Zentiva Pharma UK Ltd) 60 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/06/duaklir-1280x854.png)
Duaklir 340micrograms/dose / 12micrograms/dose Genuair (Zentiva Pharma UK Ltd) 60 dose - RightBreathe
![Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) - Clinical Trials Arena Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/2l-image-65.jpg)
Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) - Clinical Trials Arena
![Genuair® in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler | Therapeutic Delivery Genuair® in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde.14.49/asset/images/medium/figure1.gif)
Genuair® in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler | Therapeutic Delivery
Duaklir Genuair 340 micrograms /12 micrograms inhalation powder - Summary of Product Characteristics (SmPC) - (emc)
![Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD - ScienceDirect Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095461110900239X-gr1.jpg)
Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD - ScienceDirect
![Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire](https://mms.businesswire.com/media/20191020005073/en/750933/5/DUAKLIR_Inhaler_HighRes_ThreeQuarter_Capped_CMYK.jpg)
Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire
![The Genuair® inhaler: a novel, multidose dry powder inhaler - Chrystyn - 2012 - International Journal of Clinical Practice - Wiley Online Library The Genuair® inhaler: a novel, multidose dry powder inhaler - Chrystyn - 2012 - International Journal of Clinical Practice - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7832c332-2f77-43e5-aabb-f582aea873bc/ijcp_2832_f2.gif)